行情

DRIO

DRIO

DarioHealth
NASDAQ

实时行情|Nasdaq Last Sale

6.96
-1.34
-16.12%
交易中 15:07 12/10 EST
开盘
8.04
昨收
8.30
最高
8.04
最低
6.74
成交量
7.44万
成交额
--
52周最高
18.60
52周最低
3.440
市值
1,521.09万
市盈率(TTM)
-0.0368
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

DRIO 新闻

  • A New Small Account Challnege: Higher By 50% In The First Week
  • Benzinga.4天前
  • A New Small Account Challnege: Higher By 50% In The First Week
  • Benzinga.4天前
  • DarioHealth up 62% on Walmart launch of diabetes platform
  • seekingalpha.6天前
  • Mid-Afternoon Market Update: DarioHealth Jumps On Walmart Distribution Deal; Cara Therapeutics Shares Plummet
  • Benzinga.12/03 19:28

更多

所属板块

医疗设备、用品及经销
0.00%
医疗设备和用品
+0.09%

热门股票

名称
价格
涨跌幅

DRIO 简况

DarioHealth Corp, formerly Labstyle Innovations Corp, is a digital health (mHealth) company. The Company is engaged in developing and commercializing a technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The Company's product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with a pocket-sized, blood glucose monitoring device, Dario Smart Meter. The Dario product is a digital diabetes management solution utilizing its technology delivered through a software application available for iPhone or Android and cloud-based data services with a blood glucose monitoring system device. Dario allows users to record, analyze, transmit and store various data points, such as glucose level, insulin and carbohydrate intake. It markets the Dario Smart Diabetes Management Solution in the Netherlands and New Zealand.
展开

Webull提供DarioHealth Corp的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。